Eliem Therapeutics, INC. (CLYM) — SC 13D/A Filings

All SC 13D/A filings from Eliem Therapeutics, INC.. Browse 7 SC 13D/A reports with AI-powered summaries and risk analysis.

SC 13D/A Filings (7)

AI ETI LLC Amends Eliem Therapeutics Stake — Aug 16, 2024 Risk: medium
AI ETI LLC, an affiliate of Access Industries, has amended its Schedule 13D filing regarding Eliem Therapeutics, Inc. as of August 16, 2024. The filing indicate
RA Capital Amends Eliem Therapeutics Stake Filing — Jul 1, 2024 Risk: medium
RA Capital Management, L.P. and its affiliates, including Peter Kolchinsky and RA Capital Healthcare Fund, L.P., have amended their Schedule 13D filing regardin
RA Capital Amends Eliem Therapeutics Stake — Jun 6, 2024 Risk: medium
RA Capital Management, L.P. and its affiliates, including Peter Kolchinsky and Ra HealthCare Fund, L.P., have amended their Schedule 13D filing for Eliem Therap
AI ETI LLC Amends Eliem Therapeutics Stake — May 17, 2024 Risk: medium
AI ETI LLC, an affiliate of Access Industries, has amended its Schedule 13D filing for Eliem Therapeutics, Inc. on May 17, 2024. The filing indicates a change i
RA Capital Management Amends Eliem Therapeutics Stake — May 17, 2024 Risk: medium
RA Capital Management, L.P. and its affiliates, including Peter Kolchinsky and RA Capital Healthcare Fund, L.P., have amended their Schedule 13D filing regardin
RA Capital Adjusts Eliem Therapeutics Stake — Apr 12, 2024 Risk: medium
RA Capital Management, L.P. and its affiliates, including Peter Kolchinsky and Ra Health Care Fund, L.P., have amended their Schedule 13D filing regarding Eliem
RA Capital Adjusts Eliem Therapeutics Stake — Mar 18, 2024 Risk: medium
RA Capital Management, L.P. and its affiliates, including Peter Kolchinsky and Ra HealthCare Fund, L.P., have amended their Schedule 13D filing regarding Eliem

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX